NCT05424315View on ClinicalTrials.gov

Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Anterior MI
Interventions
DRUG

Dapagliflozin 10mg

10mg Tab once daily

DRUG

Glucose Tab

Placebo Oral Tablet

Trial Locations (2)

Unknown

Cardiology Department, Faculty of Medicine, Ain Shams University, Cairo

National Heart Institute, Cairo

All Listed Sponsors
collaborator

Ain Shams University

OTHER

lead

Omar Younis

OTHER_GOV

NCT05424315 - Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients | Biotech Hunter | Biotech Hunter